Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-α inhibition [13]

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 627-629

  Wachter, T ^a   Murach, W M ^a   Brocker E B ^a   Schon M P ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; ETANERCEPT; ETRETIN; FUMARIC ACID; INFLIXIMAB; LITHIUM; METHOTREXATE; MIRTAZAPINE; OLANZAPINE; RETINOID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HISTORY OF MEDICINE; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; MENTAL HOSPITAL; PRIORITY JOURNAL; PSORIASIS; SUICIDE ATTEMPT; SYSTEMIC THERAPY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; IMMUNOGLOBULIN G; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SUICIDE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547916810     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08052.x     Document Type: Letter

References (10)

1. Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005 352 : 1899 912.
2. Shastry BS. Bipolar disorder: an update. Neurochem Int 2005 46 : 273 9.
3. Muller-Oerlinghausen B. Arguments for the specificity of the antisuicidal effect of lithium. Eur Arch Psychiatry Clin Neurosci 2001 251 (Suppl. 2 : II 72 5.
4. Tondo L, Ghiani C, Albert M. Pharmacologic interventions in suicide prevention. J Clin Psychiatry 2001 62 (Suppl. 25 51 5.
5. Yeung CK, Chan HH. Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol 2004 5 : 3 8.
6. Knijff EM, Kupka R, Ruwhof C et al. Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis. Bipolar Disord 2005 7 : 388 9.
7. Leonard BE. Changes in the immune system in depression and dementia: causal or co-incidental effects? Int J Dev Neurosci 2001 19 : 305 12.
8. Prins M, Krabbe PF, Swinkels QO et al. The effect of treatment on quality of life in psoriasis patients. Acta Derm Venereol (Stockh) 2005 85 : 304 10.
9. Tyring S, Gottlieb A, Papp K et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006 367 : 29 35.
10. Schön MP. Advances in psoriasis treatment. Lancet 2005 366 : 1333 5.